Evidence map›Paper›PMID 27820602›Full record

ArticleNature neuroscience2016

An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.

Makoto Inoue, Po-Han Chen, Stephen Siecinski, Qi-Jing Li, Chunlei Liu, Lawrence Steinman, Simon G Gregory, Eric Benner, Mari L Shinohara

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. NLRP3 inflammasome in neurodegenerative disease.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Role of Semaphorins in Ischemic Stroke.Frontiers in molecular neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Makoto InoueDepartment of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
Po-Han ChenDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.
Stephen SiecinskiDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Qi-Jing LiDepartment of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
Chunlei LiuDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, California, USA.
Lawrence SteinmanDepartment of Neurology and Neurological Sciences, Stanford University, Beckman Center for Molecular Medicine, Stanford, California, USA.
Simon G GregoryDuke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Eric BennerDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Mari L ShinoharaDepartment of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-6808-9844
Duke University · USStanford University · USUniversity of California, Berkeley · USUniversity of Illinois Urbana-Champaign · US

Funding

INTEGRATED CENTER FOR IN VIVO MICROSCOPYP41EB015897 · NIBIB · DUKE UNIVERSITY · PI JOHNSON, GEORGE ALLAN · 2012 to 2017
$7.4M
Center for Molecular &Cellular Studies of Ped DiseaseK12HD043494 · NICHD · DUKE UNIVERSITY · PI REED, ANN M. · 2003 to 2017
$5.2M
Role of osteopontin in innate immunity during infections and inflammationR01AI088100 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2011 to 2021
$4.3M
Brain neuron damage-mediated respiratory failure and mortality during Cryptococcus-associated immune reconstitution inflammatory syndrome in miceR01AI136999 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI INOUE, MAKOTO · 2019 to 2023
$1.9M
Ultra-Resolution Imaging of Brain Circuitry and its Development in Mental HealthR01MH096979 · NIMH · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIU, CHUNLEI · 2013 to 2017
$1.8M
Defining the Functional Role of a Novel MS Susceptibility Gene, IL7R alpha chainR01NS060925 · NINDS · DUKE UNIVERSITY · PI GREGORY, SIMON G · 2009 to 2013
$1.7M
Regulation of innate inflammation by CD40 signaling and intracellular osteopontinR21AI103584 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2014 to 2015
$432k
NIAID NIH HHS R01 AI088100NIAID NIH HHS R21 AI103584NIBIB NIH HHS P41 EB015897NICHD NIH HHS K12 HD043494NIMH NIH HHS R01 MH096979NINDS NIH HHS R01 NS060925
6 · The paper itself

Abstract

Inflammation induced by innate immunity influences the development of T cell-mediated autoimmunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). We found that strong activation of innate immunity induced Nod-like receptor protein 3 (NLRP3) inflammasome-independent and interferon-β (IFNβ)-resistant EAE (termed type B EAE), whereas EAE induced by weak activation of innate immunity requires the NLRP3 inflammasome and is sensitive to IFNβ treatment. Instead, an alternative inflammatory mechanism, including membrane-bound lymphotoxin-β receptor (LTβR) and CXC chemokine receptor 2 (CXCR2), is involved in type B EAE development, and type B EAE is ameliorated by antagonizing these receptors. Relative expression of Ltbr and Cxcr2 genes was indeed enhanced in patients with IFNβ-resistant multiple sclerosis. Remission was minimal in type B EAE due to neuronal damages induced by semaphorin 6B upregulation on CD4

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalAnimalsCentral Nervous SystemDisease Models, AnimalHumansImmunity, InnateInflammasomesInterferon-betaLymphotoxin beta ReceptorMice, KnockoutMultiple SclerosisNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, Interleukin-8BT-LymphocytesInflammasomesInterferon-betaLTBR protein, humanLtbr protein, mouseLymphotoxin beta ReceptorNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanNlrp3 protein, mouseReceptors, Interleukin-8B

Identifiers

PMID27820602
PMCPMC5482232
OpenAlexW2552249585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.